Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJiamiao Weng, Fan Lin
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cancer statistics
2025
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024
Global epidemiology of lung cancer
2019
Tumor metastasis: molecular insights and evolving paradigms
10.1016/j.cell.2011.09.024 · 2011
Multi-stage mechanisms of tumor metastasis and therapeutic strategies
10.1038/s41392-024-01955-5 · 2024
Epithelial-mesenchymal transition: the history, regulatory mechanism, and cancer therapeutic opportunities
2020
Unresolved complexity in the gene regulatory network underlying EMT
10.3389/fonc.2020.00554 · 2020
EMT transition states during tumor progression and metastasis
10.1016/j.tcb.2018.12.001 · 2019
JAM3: a prognostic biomarker for bladder cancer via epithelial-mesenchymal transition regulation
10.17305/bb.2024.9979 · 2024
Metabolic reprogramming and cancer progression
10.1126/science.aaw5473 · 2020
Hallmarks of cancer: the next generation
10.1016/j.cell.2011.02.013 · 2011
Oxidative phosphorylation as an emerging target in cancer therapy
10.1158/1078-0432.ccr-17-3070 · 2018
Fucosylated exosomal miRNAs as promising biomarkers for the diagnosis of early lung adenocarcinoma
2022
Tumor-suppressive miR-4732-3p is sorted into fucosylated exosome by hnRNPK to avoid the inhibition of lung cancer progression
10.1186/s13046-024-03048-1 · 2024
Angiogenesis and EMT regulators in the tumor microenvironment in lung cancer and immunotherapy
10.3389/fimmu.2024.1509195 · 2024
The application of nanoparticles in cancer immunotherapy: targeting tumor microenvironment
2021
Metabolic reprogramming and interventions in angiogenesis
10.1016/j.jare.2024.05.001 · 2025
Mechanisms of action of angiogenin
10.1111/j.1745-7270.2008.00442.x · 2008
ANG secretion predisposes endothelial cells toward angiogenesis in FIN56-induced ferroptotic hepatocellular carcinoma via the BMP6/ID1 signaling pathway
10.1016/j.freeradbiomed.2025.06.029 · 2025
miR-409-3p inhibits HT1080 cell proliferation, vascularization and metastasis by targeting angiogenin
10.1016/j.canlet.2012.04.010 · 2012
Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance
10.1007/s00432-021-03874-2 · 2022
Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression
10.1038/s41392-023-01710-2 · 2023
Super enhancer-regulated LncRNA LINC01089 induces alternative splicing of DIAPH3 to drive hepatocellular carcinoma metastasis
10.1158/0008-5472.can-23-0544 · 2023
Let-7a regulates EV secretion and mitochondrial oxidative phosphorylation by targeting SNAP23 in colorectal cancer
10.1186/s13046-020-01813-6 · 2021
Aberrant energy metabolism in tumors and potential therapeutic targets
10.1002/gcc.70008 · 2024
Phospholipase D6 activates Wnt/β-catenin signaling through mitochondrial metabolic reprogramming to promote tumorigenesis in colorectal cancer
10.1038/s12276-025-01446-9 · 2025
miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer
10.1186/s12943-017-0723-7 · 2017
The role of miR-92b-3p in notch signaling and monitoring of oral squamous cell carcinoma
10.1038/s41388-025-03306-2 · 2025
Extracellular vesicles derived from melanoma cells induce carcinoma-associated fibroblasts via miR-92b-3p mediated downregulation of PTEN
10.1002/jev2.12509 · 2024
Potential of peptide-engineered exosomes with overexpressed miR-92b-3p in anti-angiogenic therapy of ovarian cancer
2021
MicroRNA: a signature for cancer progression
10.1016/j.biopha.2021.111528 · 2021
miRNA-based biomarkers, therapies, and resistance in cancer
10.7150/ijbs.47203 · 2020
Molecular and clinical characterization of ANG expression in gliomas and its association with tumor-related immune response
2023
Role of tRNA-derived small RNAs(tsRNAs) in the diagnosis and treatment of malignant tumours
10.1186/s12964-023-01199-w · 2023
BAF53A drives colorectal cancer development by regulating DUSP5-mediated ERK phosphorylation
10.1038/s41419-022-05499-w · 2022
The suppression of DUSP5 expression correlates with paclitaxel resistance and poor prognosis in basal-like breast cancer
10.7150/ijms.24981 · 2018
Long non-coding RNA ARAP1-AS1 promotes the proliferation and migration in cervical cancer through epigenetic regulation of DUSP5
10.1080/15384047.2020.1806641 · 2020
Multivalent tyrosine kinase inhibition promotes T cell recruitment to immune-desert gastric cancers by restricting epithelial-mesenchymal transition via tumour-intrinsic IFN-γ signalling
10.1136/gutjnl-2022-329134 · 2023
Cancer resistance and metastasis are maintained through oxidative phosphorylation
10.1016/j.canlet.2024.216705 · 2024
The nuclear factor kappa B (NF-κB) signaling pathway is involved in ammonia-induced mitochondrial dysfunction
10.1016/j.mito.2020.12.008 · 2021
Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics
10.1093/nar/gkae973 · doi-reference
Bruceine A: suppressing metastasis via MEK/ERK pathway and invoking mitochondrial apoptosis in triple-negative breast cancer
10.1016/j.biopha.2023.115784 · doi-reference
Extracellular ATP activates the PLC/PKC/ERK signaling pathway through the P2Y2 purinergic receptor leading to the induction of early growth response 1 expression and the inhibition of viability in human endometrial stromal cells
10.1016/j.cellsig.2008.02.011 · doi-reference